RE:RE:RE:RE:My thoughts True mil man
To the point here is what they said as well:
"FSD Pharma routinely announces investing in other small cannabis companies, but so far has shown little follow-through.
We have a price target on FSD of C$0.09 per share, which was its pre-RTO financing price less than a year ago"
whitepoint research
I suppose one could add other small biotech firms
Prescient assessment IMO